Page last updated: 2024-10-31

midazolam and Histiocytosis, Sinus

midazolam has been researched along with Histiocytosis, Sinus in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Histiocytosis, Sinus: Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ortiz, JR1
Kadri, C1

Other Studies

1 other study available for midazolam and Histiocytosis, Sinus

ArticleYear
[Anesthesia in a patient with Rosai-Dorfman disease].
    Revista espanola de anestesiologia y reanimacion, 1998, Volume: 45, Issue:10

    Topics: Adjuvants, Anesthesia; Adolescent; Androstanols; Anesthesia, Inhalation; Anesthesia, Intravenous; An

1998